RadNet Hosts Prostate Cancer Awareness Webinar Amid Screening Disparities
Event summary
- RadNet will host a free prostate cancer webinar on September 19, 2026, featuring a radiologist, urologist, robotic surgeon, and cancer survivor.
- The webinar will discuss prostate cancer risk, screening, diagnosis, treatment, and advances in prostate MRI and AI imaging technologies.
- Approximately 333,830 new prostate cancer cases are expected in the U.S. in 2026, yet only 37% of men aged 50+ have had a PSA test in the past year.
- RadNet's Enhanced Prostate Screening combines prostate MRI with AI to improve cancer detection.
The big picture
RadNet's webinar underscores the growing emphasis on early cancer detection through advanced imaging technologies. The event highlights disparities in screening rates between prostate and breast cancer, despite similar incidence and mortality rates. RadNet's integration of AI with prostate MRI positions it at the forefront of diagnostic innovation, though broader adoption will depend on shifting patient behaviors and payer policies.
What we're watching
- Adoption Pace
- How quickly RadNet can drive uptake of its Enhanced Prostate Screening among at-risk male populations.
- Competitive Positioning
- Whether RadNet's focus on prostate cancer screening differentiates it from other diagnostic imaging providers.
- Regulatory Influence
- The extent to which government or insurer policies may impact reimbursement for advanced prostate cancer screening.
Related topics